AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 34 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,507,000 | +13.9% | 5,000,000 | 0.0% | 0.03% | +3.6% |
| Q2 2020 | $3,956,000 | +2.2% | 5,000,000 | 0.0% | 0.03% | -6.7% |
| Q1 2020 | $3,870,000 | -6.0% | 5,000,000 | 0.0% | 0.03% | +50.0% |
| Q4 2019 | $4,118,000 | -0.8% | 5,000,000 | 0.0% | 0.02% | -13.0% |
| Q3 2019 | $4,150,000 | +3.5% | 5,000,000 | 0.0% | 0.02% | +4.5% |
| Q2 2019 | $4,009,000 | -53.9% | 5,000,000 | -50.0% | 0.02% | -59.3% |
| Q1 2019 | $8,691,000 | -5.5% | 10,000,000 | 0.0% | 0.05% | -11.5% |
| Q4 2018 | $9,198,000 | -12.4% | 10,000,000 | 0.0% | 0.06% | +5.2% |
| Q3 2018 | $10,499,000 | +2.2% | 10,000,000 | 0.0% | 0.06% | -7.9% |
| Q2 2018 | $10,270,000 | -1.6% | 10,000,000 | 0.0% | 0.06% | -7.4% |
| Q1 2018 | $10,437,000 | +20.5% | 10,000,000 | 0.0% | 0.07% | +54.5% |
| Q4 2017 | $8,658,000 | -10.8% | 10,000,000 | 0.0% | 0.04% | -41.3% |
| Q3 2017 | $9,704,000 | +0.8% | 10,000,000 | 0.0% | 0.08% | +5.6% |
| Q2 2017 | $9,629,000 | – | 10,000,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 8,800,000 | $9,006,000 | 7.74% |
| STEELHEAD PARTNERS LLC | 49,265,000 | $50,805,000 | 4.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,025,000 | $39,317,000 | 2.35% |
| CAMDEN ASSET MANAGEMENT L P /CA | 25,875,000 | $26,415,000 | 0.87% |
| Opera Trading Capital | 4,500,000 | $4,620,000 | 0.74% |
| Telemetry Investments, L.L.C. | 1,500,000 | $1,531,000 | 0.58% |
| SSI INVESTMENT MANAGEMENT LLC | 5,500,000 | $5,615,000 | 0.46% |
| AQR Arbitrage LLC | 32,975,000 | $33,746,000 | 0.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 31,050,000 | $32,023,000 | 0.41% |
| City Financial Investment Co Ltd | 7,500,000 | $7,862,000 | 0.40% |